A broad and potent neutralization epitope in SARS-related coronaviruses

Mostrar otras versiones (1)

Many neutralizing antibodies (nAbs) elicited to ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through natural infection and vaccination have reduced effectiveness to SARS-CoV-2 variants. Here, we show that therapeutic antibody ADG20 is able to neutralize SARS-CoV-2 variants...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meng, Zhu, Xueyong, He, Wan-ting, Zhou, Panpan, Kaku, Chengzi I., Capozzola, Tazio, Zhu, Connie Y., Yu, Xinye, Liu, Hejun, Yu, Wenli, Hua, Yuanzi, Tien, Henry, Peng, Linghang, Song, Ge, Cottrell, Christopher A., Schief, William R., Nemazee, David, Walker, Laura M., Andrabi, Raiees, Burton, Dennis R., Wilson, Ian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304036/
https://www.ncbi.nlm.nih.gov/pubmed/35767670
http://dx.doi.org/10.1073/pnas.2205784119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304036/
https://www.ncbi.nlm.nih.gov/pubmed/35767670
http://dx.doi.org/10.1073/pnas.2205784119

Ejemplares similares